Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alan Packard"'
Autor:
Ronald Seidel, Mohammad Rashidian, Stad Zeigler, Andrew Woodham, Mengyan Li, Ella Zeyang, Stephen Kolifrath, Kaitlyn O’Connor, Rodolfo Chaparro, Maia Mesyngier, Ross Cheloha, Jason Dearling, Phaneendra Duddempudi, Alev Celikgil, Scott Garforth, Alan Packard, Harris Goldstein, Hidde Ploegh, Steven Almo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c911b330d5f445948d01a28f9e0ba4c0
Autor:
Alan, Packard, Tina M, Buehner
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 62(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81a7c0920a684bbca0b5601f3f68a047
https://pubmed.ncbi.nlm.nih.gov/33622966
https://pubmed.ncbi.nlm.nih.gov/33622966
Autor:
Hyewon, Hyun, Alan, Packard
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 62(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26efcc7f3d37420fd39155e710f080a0
https://pubmed.ncbi.nlm.nih.gov/33334913
https://pubmed.ncbi.nlm.nih.gov/33334913
Autor:
Alan Packard, Bryon L. Livingston
Publikováno v:
Journal - American Water Works Association. 104:69-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9f4eadd50fe867cb9626bb5f2edb5a9
https://doi.org/10.5942/jawwa.2012.104.0012
https://doi.org/10.5942/jawwa.2012.104.0012
Publikováno v:
Therapeutic delivery. 2(5)
Radioimmunotherapy (RIT) is a cancer treatment that exploits the specific targeting capability of monoclonal antibodies to deliver cytotoxic radionuclides to antigen-expressing tumor cells or stromal targets. While this has been extremely successful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::577c2b6d02a2eefcf1f89ee923eca0d5
https://pubmed.ncbi.nlm.nih.gov/22833974
https://pubmed.ncbi.nlm.nih.gov/22833974
Autor:
Alan Packard
The objective of this project is the development of a PET radiopharmaceutical for the evaluation of multidrug resistance (mdr) in breast cancer. Multidrug resistance is resistance of a lesion to a specific class of drugs that includes many of the che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d88b70a3a62a70e5c514b5779d78ee39
https://doi.org/10.21236/ada391036
https://doi.org/10.21236/ada391036
